top of page
titali-09.png

Titali-M

An effective oral treatment for Mastitis

Mycon Pharma Product page icons-05.png
Mycon Pharma Product page icons-04.png
100 natural-04-04.png

Titali-M is an oral treatment designed to control mastitis by enhancing udder immunity, strengthening the keratin layer of the teat canal lumen, and boosting the udder's defense mechanism.

 

It is a polyherbal oral formulation indicated for the prevention and treatment of mastitis, working as a non-irritant antibacterial, anti-inflammatory, and protective emollient for the udder and teats.

​

Titali-M effectively controls microbial growth, ensuring optimal hygiene, udder health, and improved productivity of the mammary gland.

KEY BENEFITS

​

  • Treatment of Sub-Clinical/Clinical Mastitis

  • As prophylactic to control Mastitis

  • Co-Treatment in Clinical/Acute Mastitis

  • For improving Milk Quality

  • For promoting Udder health

DOSAGE

20 Tabs / Caps per Day for 3 Days or as directed by the veterinarian

tITALI M UPPER.jpg

USAGE RECOMMENDATIONS

Titali-M is a highly effective oral treatment for mastitis. The herbal ingredients used in Titali-M possess strong bactericidal properties, effectively targeting both Gram-positive and Gram-negative bacteria.

​

For optimal udder health, all animals should be routinely treated with Titali-M at the time of drying off. It is recommended to initiate treatment immediately at the first signs of mastitis to prevent progression. Additionally, prophylactic treatment of other animals in the herd with Titali-M can help reduce the risk of mastitis outbreaks.

Clinical/Controlled Trials:

1. Efficacy of Herbal Preparation on Subclinical Mastitis in Buffaloes:

  • The incidence of subclinical mastitis (SCM) was high, as detected by indirect tests and confirmed by microbiological examination.

  • Titali-M administered orally showed 100% efficacy.

​

2. Treatment of Subclinical Mastitis with Indigenous Drug 'Titali-M':

  • Animals treated only with Titali-M, without antibiotics.

  • Efficacy in SCM was 85.71% animal-wise and 83.33% on a quarter basis.

  • Improvements observed: Fat increased by 2.92%, Solid-Not-Fat (SNF) increased by 8.08%, and Milk Yield increased by 3.88%.

  • Conclusion: Qualitative and quantitative improvement in milk after treatment.

​

3. Effect of Titali-M in Mastitis:

  • In per-acute and acute cases, results were astonishing, fully controlling microbial flora and inflammation locally.

  • In chronic cases, progress was slow but resulted in a permanent cure, which is a significant achievement.

Reach out for
product details.

titali M lower image.jpg

This Site is not intended to provide diagnosis, treatment or medical advice. Products, services, information and other content provided on this Site, including information that may be provided on this Site directly or by linking to third-party websites are provided for informational purposes only.

Mycon logo-02.png

Registered Office

647, Kasba Peth Rd, Manik Chowk, Kasba Peth, Pune, Maharashtra, India - 411011

Contact

email (1).png
phone-call (2).png

86009 94558/ 97662 22726

© 2024 myconpharma All Right Reserved.

bottom of page